Literature DB >> 8530934

Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment.

J Harrison1, L Henderson, C Kennard.   

Abstract

Two pairwise matched groups of patients with mild to moderate Parkinson's disease and a group of normal age matched controls were used to investigate the effects on simple and choice reaction time (RT) of brief withdrawal of levodopa therapy. Comparisons within and across these groups disclosed a selective effect of levodopa withdrawal. After about 12 hours of levodopa deprivation, patients exhibited an exaggeration of normal refractoriness, the well established tendency for RT to increase progressively as the delay between a response and the next imperative signal is reduced below 0.5 s. Increased refractoriness was at least as great for simple as choice RT. Choice RT on trials involving repetition (as opposed to alternation) of the previous response, however, showed no tendency towards greater impairment by brevity of the recovery period or by withdrawal of medication, eliminating an effector based account. With longer recovery periods, RT was unaffected by medication; indeed, unmedicated patients were as fast as normal subjects under these conditions. Even at the briefest delays, fully medicated patients did not differ from normal controls. The paper concludes with a critical review of chronometric studies of medication effects in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530934      PMCID: PMC1073712          DOI: 10.1136/jnnp.59.5.499

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Cognitive components of reaction time in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

Authors:  S L Pullman; R L Watts; J L Juncos; T N Chase; J N Sanes
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

4.  Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.

Authors:  S L Pullman; R L Watts; J L Juncos; J N Sanes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

5.  Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

Authors:  R D Rafal; M I Posner; J A Walker; F J Friedrich
Journal:  Brain       Date:  1984-12       Impact factor: 13.501

6.  Cognitive slowing in decision tasks in early and advanced Parkinson's disease.

Authors:  P Zimmermann; R Sprengelmeyer; B Fimm; C W Wallesch
Journal:  Brain Cogn       Date:  1992-01       Impact factor: 2.310

7.  Performance of a bimanual load-lifting task by parkinsonian patients.

Authors:  F Viallet; J Massion; R Massarino; R Khalil
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

8.  Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.

Authors:  F Girotti; F Carella; M P Grassi; P Soliveri; R Marano; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

9.  Neuropsychological correlates of brain atrophy in Parkinson's disease: a CT-scan study.

Authors:  S E Starkstein; R Leiguarda
Journal:  Mov Disord       Date:  1993       Impact factor: 10.338

10.  The movement speed/accuracy operator in Parkinson's disease.

Authors:  E B Montgomery; J Nuessen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

View more
  7 in total

1.  Impaired auditory-to-motor entrainment in Parkinson's disease.

Authors:  Erik S Te Woerd; Robert Oostenveld; Floris P de Lange; Peter Praamstra
Journal:  J Neurophysiol       Date:  2017-02-08       Impact factor: 2.714

2.  Cognitive slowing in Parkinson's disease resolves after practice.

Authors:  D Z Press; D J Mechanic; D Tarsy; D S Manoach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

3.  Saccadic latency distributions in Parkinson's disease and the effects of L-dopa.

Authors:  A W Michell; Z Xu; D Fritz; S J G Lewis; T Foltynie; C H Williams-Gray; T W Robbins; R H S Carpenter; R A Barker
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

4.  Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms.

Authors:  Elmar H Pinkhardt; Reinhart Jürgens; Dorothée Lulé; Johanna Heimrath; Albert C Ludolph; Wolfgang Becker; Jan Kassubek
Journal:  BMC Neurol       Date:  2012-02-29       Impact factor: 2.474

5.  Visuo-manual tracking: does intermittent control with aperiodic sampling explain linear power and non-linear remnant without sensorimotor noise?

Authors:  Henrik Gollee; Peter J Gawthrop; Martin Lakie; Ian D Loram
Journal:  J Physiol       Date:  2017-10-01       Impact factor: 5.182

6.  Which Cognitive Domains are Improved by Treatment with Vortioxetine?

Authors:  John E Harrison; Søren Lophaven; Christina K Olsen
Journal:  Int J Neuropsychopharmacol       Date:  2016-05-26       Impact factor: 5.176

7.  Quantifying upper limb motor impairment in people with Parkinson's disease: a physiological profiling approach.

Authors:  Lewis A Ingram; Vincent K Carroll; Annie A Butler; Matthew A Brodie; Simon C Gandevia; Stephen R Lord
Journal:  PeerJ       Date:  2021-02-05       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.